<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>20813594</identifier>
<setSpec>1695-9531</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Del Toro, M</dc:author>
<dc:author>Aldámiz-Echevarría, L</dc:author>
<dc:author>Dalmau, J</dc:author>
<dc:author>Blasco, J</dc:author>
<dc:author>Díaz, C</dc:author>
<dc:author>Marrero, M</dc:author>
<dc:author>Navas, V M</dc:author>
<dc:author>Couce, M L</dc:author>
<dc:author>Leao, E</dc:author>
<dc:author>Bueno, M A</dc:author>
<dc:author>Baldellou, A</dc:author>
<dc:author>Lama, R</dc:author>
<dc:author>De La Vega, A</dc:author>
<dc:author>Pintos, G</dc:author>
<dc:description xml:lang="en">Tyrosinemia type I is a potentially lethal disease if not diagnosed and treated properly. Diagnostic and therapeutic advances in recent years have significantly improved the prognosis for these patients. It is therefore important that the pediatrician has a clinical practice guideline with recommendations for diagnosis and treatment of this disease that leads to the appropriate intervention.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2010 Nov </dc:date>
<dc:title xml:lang="es">Recomendaciones y manejo de la tirosinemia hereditaria Tipo I o Tirosinemia hepatorrenal.</dc:title>
<dc:title xml:lang="en">[Recommendations and management of type I hereditary or hepatorenal tyrosinemia].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
